EDGAR Filing Documents for 0001319244-22-000159

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

SEC Accession No. 0001319244-22-000159

Filing Date

2022-02-14

Accepted

2022-02-14 15:36:58

Documents

Group Members

ICS OPPORTUNITIES II LLCINTEGRATED ASSETS II LLCINTEGRATED ASSETS, LTD.INTEGRATED CORE STRATEGIES (US) LLCISRAEL A. ENGLANDERMILLENNIUM GROUP MANAGEMENT LLCMILLENNIUM INTERNATIONAL MANAGEMENT LPMILLENNIUM MANAGEMENT LLCRIVERVIEW GROUP LLC

Document Format Files

Seq	Description	Document	Type	Size
1		PNT_SC13GA1.htm	SC 13G/A	165100
	Complete submission text file	0001319244-22-000159.txt		167163

Mailing Address 399 PARK AVENUE NEW YORK NY 10022

Business Address 399 PARK AVENUE NEW YORK NY 10022 (212) 841-4100

RIVERVIEW GROUP LLC (Filed by) CIK: 0001273091 (see all company filings)

IRS No.: 980330397 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268

Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (647) 401-2182

POINT Biopharma Global Inc. (Subject) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91575 | Film No.: 22630652
SIC: 2834 Pharmaceutical Preparations